Početna stranicaBCCOY • OTCMKTS
add
BICO Group 4 ADR Representing Ord Shs
Preth. zaklj. cijena
0,90 $
Godišnji raspon
0,71 $ - 1,55 $
Tržišna kapitalizacija
2,35 mlr. SEK
Prosječna količina
207,00
Vijesti s tržišta
Financijski podaci
Račun dobiti i gubitka
Prihod
Neto dohodak
(SEK) | ruj 2024.info | Godišnja promjena |
---|---|---|
Prihod | 495,50 mil. | −15,67 % |
Operativni troškovi | 312,80 mil. | −7,57 % |
Neto dohodak | −246,20 mil. | −252,22 % |
Neto profitabilnost | −49,69 | −317,56 % |
Zarada po dionici | — | — |
EBITDA | 36,90 mil. | −60,79 % |
Efektivna porezna stopa | −5,77 % | — |
Bilanca stanja
Ukupna imovina
Ukupne obveze
(SEK) | ruj 2024.info | Godišnja promjena |
---|---|---|
Gotovinska i kratkoročna ulaganja | 649,80 mil. | 15,62 % |
Ukupna imovina | 5,47 mlr. | −38,24 % |
Ukupne obveze | 2,70 mlr. | −7,93 % |
Ukupni kapital | 2,77 mlr. | — |
Dionice u optjecaju | 70,57 mil. | — |
Cijena prema knjigovodstvenoj vrijednosti | 0,02 | — |
Povrat imovine | −2,22 % | — |
Povrat kapitala | −2,58 % | — |
Tok novca
Neto promjena novca
(SEK) | ruj 2024.info | Godišnja promjena |
---|---|---|
Neto dohodak | −246,20 mil. | −252,22 % |
Gotovina od poslovanja | 45,00 mil. | 1.150,00 % |
Gotovina iz ulaganja | −27,30 mil. | 73,08 % |
Gotovina iz financiranja | −18,30 mil. | 36,90 % |
Neto promjena novca | −5,30 mil. | 95,88 % |
Slobodan tok novca | −269,76 mil. | −250,45 % |
Više
Bico Group is a bioconvergence startup that designs and supplies technologies and services to enhance biology research. It focuses on commercializing technologies for life science research as well as bioprinting, and its products often combine capabilities in artificial intelligence, robotics, multiomics, and diagnostics.
Bico Group began by producing bio-inks and bioprinters for culturing different cell types to enable applications like patient-derived implants. Bico Group was the first company to provide a standardized bio-ink product for sale over the internet.
The company has ongoing collaborations with organizations including AstraZeneca, MedImmune, MIT and Takara Bio, and its bioprinters are used for research at Harvard University, Merck, Novartis, the U.S. Army, Toyota, Johnson & Johnson and more. Wikipedia
Osnovano
27. sij 2016.
Web-lokacija
Zaposlenici
824